432 related articles for article (PubMed ID: 31211375)
1. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study.
Harris HR; Cushing-Haugen KL; Webb PM; Nagle CM; Jordan SJ; ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Modugno F; Ness RB; Moysich KB; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Berchuck A; Cramer DW; Bandera EV; Rodriguez L; Wentzensen N; Kotsopoulos J; Narod SA; McLaughlin JR; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Lindström S; Terry KL
Int J Epidemiol; 2019 Jun; 48(3):822-830. PubMed ID: 31211375
[TBL] [Abstract][Full Text] [Related]
2. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
3. The Genetic Association of Polycystic Ovary Syndrome and the Risk of Endometrial Cancer: A Mendelian Randomization Study.
Chen H; Zhang Y; Li S; Tao Y; Gao R; Xu W; Yang Y; Cheng K; Wang Y; Qin L
Front Endocrinol (Lausanne); 2021; 12():756137. PubMed ID: 34803918
[TBL] [Abstract][Full Text] [Related]
4. Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.
Zhu T; Goodarzi MO
J Clin Endocrinol Metab; 2022 Feb; 107(3):e899-e911. PubMed ID: 34669940
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
Wen Y; Wu X; Peng H; Li C; Jiang Y; Su Z; Liang H; Liu J; He J; Liang W
Breast Cancer Res Treat; 2021 Feb; 185(3):799-806. PubMed ID: 33128677
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Genetically Predicted Systemic Inflammatory Regulators and Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Chen H; Zhang Y; Li S; Tao Y; Gao R; Xu W; Yang Y; Cheng K; Wang Y; Qin L
Front Endocrinol (Lausanne); 2021; 12():731569. PubMed ID: 34646235
[TBL] [Abstract][Full Text] [Related]
7. No association effect of genetic polymorphism was observed between polycystic ovary syndrome and cardiovascular diseases risk: a mendelian randomization study.
Zhang X; Huangfu Z; Wang S
Endocrine; 2023 Dec; 82(3):695-706. PubMed ID: 37668928
[TBL] [Abstract][Full Text] [Related]
8. Maternal Polycystic Ovary Syndrome and Offspring Birth Weight: A Mendelian Randomization Study.
Gan Y; Lu D; Yan C; Zhang J; Zhao J
J Clin Endocrinol Metab; 2022 Mar; 107(4):1020-1029. PubMed ID: 34849988
[TBL] [Abstract][Full Text] [Related]
9. Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study.
Zhao Y; Xu Y; Wang X; Xu L; Chen J; Gao C; Wu C; Pan D; Zhang Q; Zhou J; Chen R; Wang Z; Zhao H; You L; Cao Y; Li Z; Shi Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32163573
[TBL] [Abstract][Full Text] [Related]
10. Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.
Harris HR; Babic A; Webb PM; Nagle CM; Jordan SJ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Modugno F; Ness RB; Moysich KB; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Berchuck A; Cramer DW; Bandera EV; Wentzensen N; Kotsopoulos J; Narod SA; Phelan CM; McLaughlin JR; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Terry KL; ;
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):174-182. PubMed ID: 29141849
[No Abstract] [Full Text] [Related]
11. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study.
Zhang N; Liao Y; Zhao H; Chen T; Jia F; Yu Y; Zhu S; Wang C; Zhang W; Liu X
Front Endocrinol (Lausanne); 2023; 14():1110341. PubMed ID: 36967791
[TBL] [Abstract][Full Text] [Related]
13. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
[No Abstract] [Full Text] [Related]
14. The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data.
Si Y; Fei Y; Ma H; Xu Y; Ning L; Li X; Ren Q
Front Endocrinol (Lausanne); 2023; 14():1229900. PubMed ID: 37745707
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
[TBL] [Abstract][Full Text] [Related]
16. The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome.
Liu D; Gao X; Pan XF; Zhou T; Zhu C; Li F; Fan JG; Targher G; Zhao J
BMC Med; 2023 Feb; 21(1):62. PubMed ID: 36800955
[TBL] [Abstract][Full Text] [Related]
17. Causal relationship between polycystic ovary syndrome and coronary artery disease: A Mendelian randomisation study.
Simons PIHG; Cornelissen MEB; Valkenburg O; Onland-Moret NC; van der Schouw YT; Stehouwer CDA; Burgess S; Brouwers MCGJ
Clin Endocrinol (Oxf); 2022 Apr; 96(4):599-604. PubMed ID: 34524719
[TBL] [Abstract][Full Text] [Related]
18. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
Jiang X; Deng Q; Stener-Victorin E
Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
[TBL] [Abstract][Full Text] [Related]
19. Age at menarche and polycystic ovary syndrome: A Mendelian randomization study.
Ma Y; Cai J; Liu LW; Hou W; Wei Z; Wang Y; Xu Y
Int J Gynaecol Obstet; 2023 Sep; 162(3):1050-1056. PubMed ID: 37128830
[TBL] [Abstract][Full Text] [Related]
20. Fetal genome predicted birth weight and polycystic ovary syndrome in later life: a Mendelian randomization study.
Liu D; Gan Y; Zhang Y; Cui L; Tao T; Zhang J; Zhao J
Front Endocrinol (Lausanne); 2023; 14():1140499. PubMed ID: 37351103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
